Our News

Our News

Find out about the latest events and advancements. This summarizes our press releases and latest events information.

2019

Two-Step Expansion and VR Technique Enlarges Tiny Microbes, Illuminating New Ways to Prevent and Treat Disease

Immunotherapy delays type 1 diabetes diagnosis in people at high risk

Parker Institute for Cancer Immunotherapy, JDRF and the Helmsley Charitable Trust Form Cancer and Diabetes Research Initiative

Discovery of New Cell Type with Link to Deadly Inflammatory Disorder

Benaroya Research Institute Welcomes Two New Board Members

2018

BRI to Partner with the Allen Institute for Immunology, a New Research Endeavor Focused on Human Immune Health and Disease

BRI Celebrates Peter Linsley, PhD, Trailblazer in Immune Regulation

BRI Awarded Funding for Autoimmune Disease Research in Down Syndrome Population

A big step toward stopping life-threatening allergies

Low-Dose Thymoglobulin® Preserves Insulin Production in People Newly Diagnosed With Type 1 Diabetes

Vitiligo Clinical Trial in the News

Lynn Rose, PhD, Promoted to Chief of Scientific Administration

A Potential New Lab Test for Food Allergy

Benaroya Research Institute Scientists Uncover New Strategy for Stopping Breast Cancer

Benaroya Research Institute Receives $5 Million Grant to Explore Personalized Treatments for Peanut Allergy

Pages